Publications by authors named "Maimoona Nadri"
Article Synopsis
- * In a study of 982 cancer patients from 2020 to 2023, most received the initial vaccine and one booster, but the uptake for the newer bivalent booster was significantly low at only 30.1%.
- * Despite low booster rates, nearly all participants showed improved immune responses after receiving at least two boosters, and those who got boosted had a lower risk of mortality, highlighting the need for better strategies to encourage vaccinations among this vulnerable group.
Clin Lung Cancer
November 2024
Article Synopsis
- SARS-CoV-2 can spread from asymptomatic individuals, posing a greater risk to cancer patients who frequently visit healthcare facilities and are more vulnerable to severe COVID-19 outcomes.*
-
- A study of lung cancer patients revealed that over half of those with evidence of SARS-CoV-2 infection were asymptomatic at diagnosis, and a significant number were never clinically diagnosed.*
-
- The findings indicate that older patients and those with early-stage lung cancer are more likely to have asymptomatic infections, highlighting the need for continued preventive measures in high-risk populations.*
Article Synopsis
- - Patients with cancer have a higher risk of severe outcomes from COVID-19 and show weakened immune responses to vaccines, highlighting the importance of regular boosters in this group
- - A study of 982 cancer patients found high initiation of vaccination (92.3% received the primary vaccine) but lower uptake of boosters, especially among younger patients and racial minorities
- - Receiving multiple booster shots significantly increased antibody levels and T-cell responses, leading to a lower risk of death, indicating the need for improved strategies to boost vaccination rates among high-risk cancer patients
Article Synopsis
- - The study investigates Post-acute COVID-19 syndrome (PACS) and its relation to organ damage, aiming to identify potential biomarkers using liquid biopsy approaches for better patient care.
- - Researchers analyzed blood samples from 100 Post-COVID patients, with varying symptoms, and 19 normal donors, finding significant differences in cellular structures suggesting endothelial and platelet features in those suspected of PACS.
- - Although a machine learning model effectively distinguished between normal donors and Post-COVID patients, it struggled to separate those suspected of PACS, indicating more research is necessary to better understand and stratify these post-COVID conditions.
